Report overview
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor?s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
This report aims to provide a comprehensive presentation of the global market for CRO in Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO in Clinical Trials. This report contains market size and forecasts of CRO in Clinical Trials in global, including the following market information:
Global CRO in Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CRO in Clinical Trials market was valued at US$ 44220 million in 2022 and is projected to reach US$ 81210 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical?with a share about 55%.
We surveyed the CRO in Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRO in Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CRO in Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Global CRO in Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CRO in Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Bio-pharm
Others
Global CRO in Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CRO in Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRO in Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRO in Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRO in Clinical Trials, market overview.
Chapter 2: Global CRO in Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of CRO in Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRO in Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
